1. E. M. de S Russo and V. F. T. Russo, 2002, Compounds in the form of homodimeric, heterodimeric and/or homo and heteromultimeric pro-drugs; process for obtaining these pro-drugs and their acceptable pharmaceutical salts and use of compounds in the treatment of phosphodiesterasis-mediated diseases or dysfunction, PCT Int. Appl., WO, vol. 2002012241, p. A8.
2. Characterization of sildenafil analogs by MS/MS and NMR: a guidance for detection and structure elucidation of phosphodiesterase-5 inhibitors;Mustazza;J. Pharm. Biomed. Anal.,2014
3. N. Müller and M. Matzke, Method for Preparing 1-Alkyl-pyrazol-5-carboxylic Acid Esters III. Google Patents, 2002.
4. L. Heuer, N. Muller, and G. Steffan, Process for the Preparation of Nitropyrazole Esters. Google Patents, 1999.
5. A. S. Bell, D. Brown, and N. K. Terrett, Pyrazolopyrimidinone Antianginal Agents. Google Patents, 1993.